Medicamen Biotech Ltd. - Research Center
531146 MEDICAMEQ Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Profit before tax | 15.00 | 14.91 | 12.49 | 12.03 | 10.11 |
| Net cashflow-operating activity | -3.50 | 4.81 | 13.29 | 4.30 | -5.45 |
| Net cash used in investing activity | -7.54 | -8.47 | -18.12 | -14.76 | -7.99 |
| Netcash used in fin. activity | 27.67 | 4.39 | 5.68 | -3.69 | 33.14 |
| Net inc/dec in cash and equivlnt | 16.63 | 0.73 | 0.85 | -14.15 | 19.70 |
| Cash and equivalnt begin of year | 3.81 | 3.08 | 2.23 | 22.66 | 2.97 |
| Cash and equivalnt end of year | 20.44 | 3.81 | 3.08 | 8.52 | 22.66 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis